Functional involvement of E-cadherin in TGF-beta 1-induced cell cluster formation of in vitro developing human Langerhans-type dendritic cells

J Immunol. 2000 Aug 1;165(3):1381-6. doi: 10.4049/jimmunol.165.3.1381.

Abstract

Epithelial Langerhans cells (LC) represent immature dendritic cells that require TGF-beta 1 stimulation for their development. Little is known about the mechanisms regulating LC generation from their precursor cells. We demonstrate here that LC development from human CD34+ hemopoietic progenitor cells in response to TGF-beta 1 costimulation (basic cytokine combination GM-CSF plus TNF-alpha, stem cell factor, and Flt3 ligand) is associated with pronounced cell cluster formation of developing LC precursor cells. This cell-clustering phenomenon requires hemopoietic progenitor cell differentiation, since it is first seen on day 4 after culture initiation of CD34+ cells. Cell cluster formation morphologically indicates progenitor cell development along the LC pathway, because parallel cultures set up in the absence of exogenous TGF-beta 1 fail to form cell clusters and predominantly give rise to monocyte, but not LC, development (CD1a-, lysozyme+, CD14+). TGF-beta 1 costimulation of CD34+ cells induces neoexpression of the homophilic adhesion molecule E-cadherin in the absence of the E-cadherin heteroligand CD103. Addition of anti-E-cadherin mAb or mAbs to any of the constitutively expressed adhesion molecule (CD99, CD31, LFA-1, or CD18) to TGF-beta 1-supplemented progenitor cell cultures inhibits LC precursor cell cluster formation, and this effect is, with the exception of anti-E-cadherin mAb, associated with inhibition of LC generation. Addition of anti-E-cadherin mAb to the culture allows cell cluster-independent generation of LC from CD34+ cells. Thus, functional E-cadherin expression and homotypic cell cluster formation represent a regular response of LC precursor cells to TGF-beta 1 stimulation, and cytoadhesive interactions may modulate LC differentiation from hemopoietic progenitor cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 12E7 Antigen
  • Antibodies, Blocking / pharmacology
  • Antibodies, Monoclonal / metabolism
  • Antibodies, Monoclonal / pharmacology
  • Antigens, CD / immunology
  • Antigens, CD34 / biosynthesis
  • CD18 Antigens / immunology
  • Cadherins / immunology
  • Cadherins / metabolism
  • Cadherins / physiology*
  • Cell Adhesion / immunology
  • Cell Adhesion Molecules / immunology
  • Cell Differentiation / immunology
  • Cells, Cultured
  • Dendritic Cells / cytology
  • Dendritic Cells / immunology
  • Growth Inhibitors / immunology
  • Growth Inhibitors / pharmacology
  • Hematopoietic Stem Cells / cytology*
  • Hematopoietic Stem Cells / immunology
  • Hematopoietic Stem Cells / metabolism
  • Humans
  • Infant, Newborn
  • Langerhans Cells / cytology*
  • Langerhans Cells / immunology
  • Langerhans Cells / metabolism
  • Ligands
  • Lymphocyte Function-Associated Antigen-1 / immunology
  • Monocytes / cytology
  • Monocytes / immunology
  • Platelet Endothelial Cell Adhesion Molecule-1 / immunology
  • Transforming Growth Factor beta / physiology*

Substances

  • 12E7 Antigen
  • Antibodies, Blocking
  • Antibodies, Monoclonal
  • Antigens, CD
  • Antigens, CD34
  • CD18 Antigens
  • CD99 protein, human
  • Cadherins
  • Cell Adhesion Molecules
  • Growth Inhibitors
  • Ligands
  • Lymphocyte Function-Associated Antigen-1
  • Platelet Endothelial Cell Adhesion Molecule-1
  • Transforming Growth Factor beta